Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

National Survey Looks At HIV/AIDS In South Africa
According to the results of a national survey conducted in 2008 and released Tuesday, HIV prevalence among South Africans between the ages of 15 and 24 dropped from "a high of 10.3 percent in 2005 to 8.7 percent last year, with the decreases most marked among teenagers," AFP/Google.com reports (AFP/Google.com, 6/9). The Telegraph writes, "HIV prevalence in children between 2 and 14 fell from 5.6 per cent in 2002 to 2.5 per cent last year, mainly thanks to the spread of drugs to prevent women passing on the virus to their children" (Telegraph, 6/10).
generic viagra online
Recent Releases: HIV Prevention; Clinical Trials Debate; Definition Of Global Health; Drug Resistant TB
Future Studies Needed To Determine If "Test And Treat" Approach Could "End HIV Pandemic Within 50 Years," Researchers Say
News of the day
Mersana Reports Preliminary Phase 1 Results Of XMT-1001 In Patients With Advanced Solid Tumors
Mersana Therapeutics presented preliminary results of a Phase 1 clinical trial for its lead development candidate, XMT-1001, in a poster session at the 2009 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando. XMT-1001 is a broad-spectrum cytotoxic, based on camptothecin (CPT), conjugated to Mersana"s biodegradable polymer platform, Fleximer(R).
Public Health

Ingelheim And The World Stroke Organization Announce Partnership In The World Stroke Academy

Boehringer Ingelheim announced today that it will become the founding sponsor of the World Stroke Academy, a novel training initiative for stroke professionals being developed by the World Stroke Organization (WSO). This latest educational initiative from the WSO will bring together an international group of stroke experts - led by Professor Michael Brainin of the Danube University Krems, Austria - to provide information about stroke and knowledge for health professionals and medical doctors in order to improve prevention, therapy and management of stroke. Professor Bo Norrving, President of the WSO said: "The World Stroke Academy is a project of the World Stroke Organization and aims at improving education on a global scale. It is a platform open to all stroke societies aiming at global effectiveness of fighting stroke and its physical and mental consequences." Dr. Manfred Haehl, Corporate Senior Vice President Medicine, Boehringer Ingelheim said: "Boehringer Ingelheim is committed to patient care and we are proud to support initiatives that have potential to benefit all patients. Stroke is one of the biggest causes of death and severe disability worldwide, and a great many patients simply don"t have access to specialist care. We hope the World Stroke Academy will contribute to training a new generation of specialists who can help provide that care." The World Health Organization estimates that 5.7 million people in the world die each year from stroke. Among survivors, 40% experience moderate to severe disability and 10% require institutional care. The World Stroke Academy aims to provide a mixture of online and conventional activities to educate and help facilitate training of stroke professionals across all regions of the world. Key objectives of the initiative include: - Promoting knowledge and education on stroke management on a global level according to the WSO mission statement - Improving and standardising educational standards in primary and secondary stroke prevention, acute management and rehabilitation - Leveraging guidelines to ensure best practice is implemented within all regions of the world - Further developing the WSO as a leading global educator. Boehringer Ingelheim


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009